The weight-loss drugs, also called anti-obesity medications or GLP-1s, mimic the hormone known as glucagon-like peptide 1, which regulates the appetite by communicating fullness between the gut and brain when people eat
The Impact: Diabetes treatment costs could drop 60-70% 72M+ Indians with diabetes gain affordable access Indian pharma captures $2B+ market opportunity GLP-1 agonists transition from premium to accessible care This isn't just about genericsit's about democratizing diabetes management
Hair loss is a patient-valued outcome, lead researcher Yong Chen wrote, adding that it can affect self-esteem, quality of life, and adherence to treatment. For many, the benefits vastly outweigh the drawbacks, but researchers said the findings should help patients understand the potential trade-offs before startingor deciding whether to continuethe highly popular medication
Hayes MR, Skibicka KP, Grill HJ